Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	834.53	812.17	822.42	597.54	415.29	258.39
Revenue Growth (YoY)	-2.39%	-1.25%	37.63%	43.89%	60.72%	43.66%
Cost of Revenue	224.38	212.67	206	152.43	118.34	70.11
Gross Profit	610.16	599.49	616.42	445.11	296.96	188.28
Selling, General & Admin	382.76	376.61	378.9	309.21	223.38	153.38
Research & Development	131.48	130.17	147.77	135.94	69.34	54.04
Other Operating Expenses	-3.88	-1.7	-1.09	-5.43	-0.22	-0.39
Operating Expenses	510.36	505.07	525.58	439.72	292.5	207.02
Operating Income	99.8	94.42	90.84	5.4	4.45	-18.74
Interest Expense	-	-3.48	-1.26	-1.19	-0.61	-0.28
Interest & Investment Income	55.9	7.88	17.16	8.85	2.12	-
Currency Exchange Gain (Loss)	-69.96	-69.96	32.39	9.69	17.09	5.98
Other Non Operating Income (Expenses)	12.39	12.39	63.04	72.78	-0.49	19.75
EBT Excluding Unusual Items	98.12	41.25	202.16	95.52	22.58	6.71
Merger & Restructuring Charges	-2.3	-2.3	-1.43	-	-	-
Gain (Loss) on Sale of Assets	-0.39	-0.39	-0.78	-1	-0.26	-0.04
Pretax Income	95.44	38.56	199.95	94.52	22.31	6.67
Income Tax Expense	21.58	13.4	27.77	2.7	3.89	-1.49
Net Income	73.86	25.16	172.18	91.82	18.43	8.15
Net Income to Common	73.86	25.16	172.18	91.82	18.43	8.15
Net Income Growth	-46.09%	-85.39%	87.52%	398.29%	126.04%	-
Shares Outstanding (Basic)	31	31	31	30	30	29
Shares Outstanding (Diluted)	32	32	32	30	30	29
Shares Change (YoY)	-0.25%	-0.29%	5.73%	1.39%	2.04%	6.49%
EPS (Basic)	2.34	0.80	5.47	3.07	0.62	0.28
EPS (Diluted)	2.34	0.80	5.44	3.07	0.62	0.28
EPS Growth	-46.06%	-85.31%	77.35%	394.72%	121.43%	-
Free Cash Flow	87.97	7.35	40.56	3.27	9.67	-22.25
Free Cash Flow Per Share	2.79	0.23	1.28	0.11	0.33	-0.77
Gross Margin	73.11%	73.81%	74.95%	74.49%	71.50%	72.87%
Operating Margin	11.96%	11.63%	11.04%	0.90%	1.07%	-7.25%
Profit Margin	8.85%	3.10%	20.94%	15.37%	4.44%	3.16%
Free Cash Flow Margin	10.54%	0.90%	4.93%	0.55%	2.33%	-8.61%
EBITDA	137.43	129.31	118.43	19.03	13.3	-11.7
EBITDA Margin	16.47%	15.92%	14.40%	3.19%	3.20%	-4.53%
D&A For EBITDA	37.63	34.9	27.59	13.64	8.85	7.04
EBIT	99.8	94.42	90.84	5.4	4.45	-18.74
EBIT Margin	11.96%	11.63%	11.04%	0.90%	1.07%	-7.25%
Effective Tax Rate	22.61%	34.74%	13.89%	2.86%	17.42%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.